drugset / Trial / NCT05279001
A Safety and Tolerability Study of Jaktinib
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying a drug called Jaktinib as a possible treatment for Myelofibrosis.
Timeline
- Start
- 2024-07-01
- Primary completion
- 2025-05-31
- Completion
- 2025-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jaktinib | Unknown | — | Oral |